Real-life effect of elexacaftor/tezacaftor/ivacaftor therapy on microbiological findings in patients with Cystic fibrosis

被引：0
|
作者：
Lucca, Francesca [1 ]
Cucchetto, Giulia [1 ]
Paiola, Giulia [1 ]
Volpiilaria, Sonia [1 ]
Meneghelli, Illaria [1 ]
Pintani, Emily [1 ]
Cipolli, Marco [1 ]
机构：
[1] Cyst Fibrosis Ctr, Verona, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.OA3775
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A real-life study of elexacaftor-tezacaftor-ivacaftor therapy in people with cystic fibrosis in Brazil
    Salomao, L. Z.
    Athanazio, R. A.
    Rached, S. Z.
    Lopes-Pacheco, M.
    Camargo, M.
    PULMONOLOGY, 2023, 29 (06): : 543 - 545
  • [2] Real-life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients
    Kos, Renate
    Neerincx, Anne H.
    Fenn, Dominic W.
    Brinkman, Paul
    Lub, Rianne
    Vonk, Steffie E. M.
    Roukema, Jolt
    Reijers, Monique H.
    Terheggen-Lagro, Suzanne W. J.
    Altenburg, Josje
    Majoor, Christof J.
    Bos, Lieuwe D.
    Haarman, Eric G.
    Maitland-van der Zee, Anke H.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (06):
  • [3] Cystic Fibrosis: Triple Therapy with Elexacaftor, Tezacaftor and Ivacaftor
    Lorenz, Judith
    PNEUMOLOGIE, 2022, 76 (03): : 153 - 153
  • [4] Unveiling the psychosocial impact of Elexacaftor/Tezacaftor/Ivacaftor therapy in Cystic Fibrosis patients
    Garcia, Marta Solis
    Pelaez, Adrian
    Punter, Rosa Mar Gomez
    Lopez, Maria Criado
    Carbajal, Claudia Madrid
    Ancochea, Julio
    Bachiller, Jose Maria Eiros
    Hernandez, Ana Sofia Martin
    Rodrigo-Garcia, Maria
    Clemente, Marta Garcia
    Moreno, Rosa Ma Giron
    BMC PULMONARY MEDICINE, 2025, 25 (01):
  • [5] 'Triple therapy' (elexacaftor, tezacaftor, ivacaftor) skin rash in patients with cystic fibrosis
    Hu, May Khei
    Wood, Genna
    Dempsey, Owen
    POSTGRADUATE MEDICAL JOURNAL, 2022, 98 (1156) : 86 - 86
  • [6] Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
    Piehler, Linus
    Thalemann, Ralf
    Lehmann, Christine
    Thee, Stephanie
    Roehmel, Jobst
    Syunyaeva, Zulfiya
    Stahl, Mirjam
    Mall, Marcus A.
    Graeber, Simon Y.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Real-life experience with a generic formulation of Elexacaftor/Tezacaftor/ Ivacaftor in patients with Cystic Fibrosis with responsive CFTR variants without previous modulators therapy
    Teper, Alejandro
    Lubovich, Silvina
    Zaragoza, Silvina
    Rodriguez, Viviana
    Rodriguez, Ezequiel
    Bracamonte, Florencia
    Ray, Lucia
    Frias, Grecia
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [8] Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1589): : 5 - 7
  • [9] Real-life impact of genotype and severity of lung disease on efficacy of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis
    Sheikh, Shahid
    Holtzlander, Melissa
    Eisner, Mariah
    Gushue, Courtney
    Palacios, Sabrina
    Kotha, Kavitha
    Imran, Sehyr
    Mccoy, Karen S.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2025, 88
  • [10] Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis
    Casey, Michelle
    Gabillard-Lefort, Claudie
    McElvaney, Oisin F.
    McElvaney, Oliver J.
    Carroll, Tomas
    Heeney, Ronan C.
    Gunaratnam, Cedric
    Reeves, Emer P.
    Murphy, Mark P.
    McElvaney, Noel G.
    THORAX, 2023, 78 (08) : 835 - 839
12345